Companies: 10,795·Total market cap: $144.5T
Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRYNASDAQFinancial Services
$11.14
$-0.03(-0.27%)
Market Cap$48302260
P/E Ratio—
52W High$12.0
52W Low$10.21
SEC Filings

Monterey Bio Acquisition Corporation (MTRY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001860663 · MTRY · NASDAQ · as of Jun 9, 2026

Filing snapshot

80
Total Filings
SC 13G/A
Latest Form
2024-02-13
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001860663 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-04-17
Fiscal Year End
Apr 17, 2023
Accession No.
0001410578-23-000670
Primary Document
mtryu-20221231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001860663 · Accession 0001410578-23-000670

Latest Key Filings

10-QQuarterly Report
10-Q
2023-08-22
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2023-12-01Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
FORM SC 13G/A
2024-02-13
View
15-12G15-12G
15-12G
2023-12-19
View
8-KCurrent Report
FORM 8-K
2023-12-01
View
25-NSE25-NSE
25-NSE
2023-11-20
View
8-KCurrent Report
FORM 8-K
2023-11-07
View
8-KCurrent Report
FORM 8-K
2023-10-13
View
10-QQuarterly Report
10-Q
2023-08-22
View
NT 10-QNT 10-Q
NT 10-Q
2023-08-15
View
8-KCurrent Report
FORM 8-K
2023-07-10
View
DEFA14AProxy Statement (Additional)
DEFA14A
2023-06-30
View
8-KCurrent Report
FORM 8-K
2023-06-30
View
8-KCurrent Report
FORM 8-K
2023-06-30
View
DEF 14AProxy Statement
DEF 14A
2023-06-16
View
PRE 14APRE 14A
PRE 14A
2023-06-02
View
10-QQuarterly Report
10-Q
2023-05-18
View
Showing 1–15 of 74 filingsForm 4 / 144 hidden· 80 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001860663  |  Exchange: NASDAQ · Financial Services

Monterey Bio Acquisition Corporation (NASDAQ: MTRY) has submitted 80 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Financial Services sector company with CIK 0001860663, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Monterey Bio Acquisition Corporation's most comprehensive regulatory disclosure. The most recent Monterey Bio Acquisition Corporation 10-K was filed on 2023-04-17 for fiscal year ending 2023. Historical MTRY 10-K annual reports are available from 2021 through 2023.

Investors researching Monterey Bio Acquisition Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Financial Services
GRDI SEC Filings →PRSR SEC Filings →ROCL SEC Filings →VSAC SEC Filings →ACAB SEC Filings →ZEO SEC Filings →HOLO SEC Filings →GTI SEC Filings →
→ MTRY Financials→ MTRY Earnings→ MTRY Insider Trades

Frequently Asked Questions

MTRY SEC Filings · 8 questions

Monterey Bio Acquisition Corporation (MTRY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 80 filings and access original documents at no cost. Monterey Bio Acquisition Corporation's CIK is 0001860663.

MTRY SEC filingsMonterey Bio Acquisition Corporation SEC documentsfind MTRY 10-K